Jonathan Strober, MD, discusses promising results from the VIBRANCE-MG trial, highlighting nipocalimab's safety and efficacy for pediatric myasthenia gravis.

Myasthenia gravis (MG) has been treatable for nearly 100 years. In 1934, the Scottish doctor Mary Broadfoot Walker, MD, discovered that the drug physostigmine improved muscle function in people with ...

The patient in this case experienced significant muscle weakness after emerging from anesthesia. A patient who emerged from general anesthesia with upper and lower extremity weakness caused worry ...

It’s a lifelong autoimmune neuromuscular disease. It causes certain muscles to weaken easily after you use them. Muscle fatigue typically varies throughout the day (sometimes hour by hour) and gets ...

Generalized myasthenia gravis is Uplizna’s second new indication this year, after the FDA cleared the anti-CD19 antibody for IgG4-related disease in April.

Francisco J. Rivera Rosario is a science communications editor experienced in developing all types of science content including, scientific journal articles, infographics, medical educational videos, ...

Developing safe and sustainable exercise habits is important, especially when you live with a condition like myasthenia gravis. Myasthenia gravis is an autoimmune condition that causes weakness in the ...

Five therapies are currently approved by the FDA for treating the symptoms of myasthenia gravis, allowing partial to complete remission. Research suggests that five new therapies may become available ...

Doctors may recommend oral medications such as pyridostigmine and various intravenous (IV) drugs for the treatment of myasthenia gravis. Thymectomy surgery and plasma exchange may also help. The aim ...

Myasthenia gravis is an autoimmune disease that blocks proper communication between your nerves and muscles, leading to weakness of your voluntary muscles (the muscles you can control and move at will ...

Myasthenia gravis is an autoimmune disease in which antibodies bind to acetylcholine receptors or to functionally related molecules in the postsynaptic membrane at the neuromuscular junction. The ...

Myasthenia gravis is a rare neuromuscular disease in which the voluntary muscles quickly become tired and weak as a result of dysfunction with nerve and muscle communication. Myasthenia gravis (MG) is ...